What Is PT-141?
PT-141, also known as Bremelanotide, is a synthetic melanocortin receptor agonist that works through the central nervous system to support libido in both men and women. Unlike vascular-based treatments, PT-141 activates melanocortin receptors in the hypothalamus that are directly involved in regulating libido. At New Results Medical Weight Loss, PT-141 is offered as part of a personalized peptide protocol for patients experiencing a decline in libido related to hormonal changes, weight fluctuations, or aging.
How PT-141 Supports Your Wellness Journey
Hormonal imbalances, significant weight changes, and metabolic disruption can all contribute to reduced libido, a concern that is often underaddressed in traditional weight loss programs. PT-141 works at the neurological level, engaging the melanocortin pathways in the brain responsible for regulating libido. Addressing libido as part of a comprehensive wellness plan supports better overall quality of life and long-term patient outcomes at New Results.
PT-141 Benefits
- Supports libido in men and women
- Acts on central nervous system melanocortin receptors
- Addresses neurologically driven factors behind reduced libido
- Does not rely on vascular or hormonal mechanisms alone
- Complements broader wellness and hormone-related peptide protocols
- Individualized dosing based on clinical evaluation and medical history

